๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Under-investigated area in prostate cancer: cross talk between the bone microenvironment and prostate cancer bone metastasis

โœ Scribed by Suresh Mohla


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
32 KB
Volume
91
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The role of tumor microenvironment in pr
โœ Colm Morrissey; Robert L. Vessella ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 396 KB ๐Ÿ‘ 2 views

## Abstract Prostate cancer (PCa) epithelial cells require a number of factors to facilitate their establishment and growth at a distant site of metastasis. Their ability to adapt to their microenvironment, proliferate and recruit an underlying stroma is integral to the survival and growth of the m

Osteomimetic properties of prostate canc
โœ Koeneman, Kenneth S.; Yeung, Fan; Chung, Leland W.K. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 317 KB ๐Ÿ‘ 1 views

## BACKGROUND. Unlike most other malignancies, prostate cancer metastasizes preferentially to the skeleton and elicits osteoblastic reactions. METHODS. We present a hypothesis, based upon results obtained from our laboratory and others, on the nature of progression of prostate cancer cells and the

Use of bone turnover marker, pyridinolin
โœ Koga, Hirofumi; Naito, Seiji; Koto, Shuji; Sakamoto, Naotaka; Nakashima, Michita ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 202 KB ๐Ÿ‘ 2 views

BACKGROUND. We investigated whether a new marker of bone turnover, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), could be useful in the assessment of bone metastasis and in monitoring of the response to treatment in patients with prostate cancer with bone metastasi

Inability of bone turnover marker as a s
โœ Akimoto, Susumu; Furuya, Yuzo; Akakura, Koichiro; Shimazaki, Jun; Ito, Haruo ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 186 KB ๐Ÿ‘ 2 views

## Background: Although clinical investigations of bone turnover markers in prostate cancer patients have been conducted, the relationships of pretreatment levels of the markers to the prognosis of patients with bone metastasis has not been fully examined. ## Methods: The serum levels of carboxy-